Buy Ajanta Pharma; target of Rs 380: Firstcall Research

Firstcall Research is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 380 in its November 10, 2011 research report.

November 29, 2011 / 14:35 IST

live

bselive
nselive

Volume

Todays L/H

Firstcall Research is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 380 in its November 10, 2011 research report.

first published: Nov 11, 2011 01:15 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347